Publication date: Mar 01, 2025
Immunocompromised individuals are at increased risk for opportunistic infections including pneumonia. Pneumonia has long been known to be a leading cause of mortality during induction chemotherapy for acute leukemia and was the first recognized presentation of human immunodeficiency virus (HIV). Even with adequate treatment, there is a wide breadth of postpneumonia sequelae, which is of particular interest in immunocompromised hosts given their increased risk for pneumonia. In this review, we describe the varying complications, presentations, and systems involved in the sequelae of immunocompromised host pneumonia. We focus on people living with HIV, a well-studied heterogenous population, to model immunocompromised hosts.
| Concepts | Keywords |
|---|---|
| Hiv | HIV |
| Immunocompromised | HIV Infections |
| Leukemia | Humans |
| Opportunistic | Immunocompromised Host |
| Pneumonia | Immunocompromised host |
| Pneumonia | |
| Pneumonia | |
| Sequelae | |
| Tuberculosis |
Semantics
| Type | Source | Name |
|---|---|---|
| disease | MESH | Sequelae |
| disease | MESH | Immunocompromised Host |
| disease | MESH | Pneumonia |
| disease | MESH | opportunistic infections |
| disease | MESH | leukemia |
| disease | IDO | immunodeficiency |
| disease | MESH | HIV Infections |
| disease | MESH | Tuberculosis |
| pathway | KEGG | Tuberculosis |